Press releases
- Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
- Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET
- Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 21.16m |
Free float | 19.87m |
P/E (TTM) | -- |
Market cap | 261.70m USD |
EPS (TTM) | -6.56 USD |
Data delayed at least 15 minutes.
More ▼